2-aminoquinoline derivatives as 5-HT ( 5A) receptor antagonists

Details for Australian Patent Application No. 2009221285 (hide)

Owner F. Hoffmann-La Roche AG

Inventors Riemer, Claus; Steward, Lucinda; Roche, Olivier; Woltering, Thomas; Wichmann, Juergen; Kolczewski, Sabine

Agent Spruson & Ferguson

Pub. Number AU-A-2009221285

PCT Pub. Number WO2009/109493

Priority 08152435.7 07.03.08 EP

Filing date 25 February 2009

Wipo publication date 11 September 2009

International Classifications

C07D 215/38 (2006.01) Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems

A61K 31/47 (2006.01) - Quinolines

A61K 31/4709 (2006.01) - Non-condensed quinolines containing further heterocyclic rings

A61P 25/00 (2006.01) Drugs for disorders of the nervous system

C07D 405/12 (2006.01) Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

Event Publications

23 September 2010 PCT application entered the National Phase

  PCT publication WO2009/109493 Priority application(s): WO2009/109493

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009221291-Dye sensitised solar cell

2009221282-System having a transmission